{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P17813",
      "entity_text" : "end",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:2244",
      "entity_text" : "aspirin",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Adjusting for age, hypertension, dyslipidemia, and history of smoking, low-dose aspirin significantly reduced primary end points in patients with eGFR 60-89 mL/min/1.73 m 2 (0.53 [0.34-0.83]; P = 0.0052), and not in patients with eGFR> = 90 or < 60 mL/min/1.73 m 2 (eGFR> = 90 mL/min/1.73 m 2 : 0.87 [0.36-2.14]; eGFR < 60 mL/min/1.73 m 2 : 1.24 [0.69-2.23]).",
  "reading_complete" : "2020-07-28T16:23:41Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T16:18:12Z",
  "trigger" : "reduced",
  "evidence" : [ "aspirin significantly reduced primary end" ],
  "pmc_id" : "3024334",
  "score" : 0
}